I. Hoffmann
发表
J. Schrenzel,
V. Lazarevic,
M. Esposito‐Farèse,
2018,
bioRxiv.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
Gabriela K. Fragiadakis,
2022,
Science immunology.
Siti Zubaidah Othman,
Karl Erik Müller,
Jose M. Mandei,
2021,
The Lancet Infectious Diseases.
Inserm,
Shana M Augustin,
C. Charpentier,
2020,
Clinical Microbiology and Infection.
C. A. Shaw,
Eglantine Ferrand Devouge,
Su Hwan Lee,
2022,
Critical Care.
M. Esposito‐Farèse,
J. Lucet,
B. Coignard,
2015,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
C. Charpentier,
J. Timsit,
J. Hulot,
2022,
Critical Care.
Siti Zubaidah Othman,
Eyvind W. Axelsen,
C. A. Shaw,
2022,
Influenza and other respiratory viruses.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
Karl Erik Müller,
Jose M. Mandei,
C. A. Shaw,
2021,
Infection.
V. Gaborieau,
A. Sommet,
R. Favory,
2021,
Fundamental & clinical pharmacology.
Andrew J. Oler,
Eglantine Ferrand Devouge,
P. Gregersen,
2023,
Genome Medicine.
Siti Zubaidah Othman,
C. A. Shaw,
Eglantine Ferrand Devouge,
2023,
Kidney International Reports.
S. Brisse,
B. Fantin,
D. Decré,
2021,
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
Mark S. Anderson,
P. Gregersen,
R. Nussbaum,
2021,
Science Immunology.
C. Charpentier,
J. Timsit,
J. Hulot,
2023,
Journal of Clinical Immunology.
Siti Zubaidah Othman,
Eyvind W. Axelsen,
C. A. Shaw,
2022,
Influenza and other respiratory viruses.
A. Rojek,
L. Merson,
J. Dunning,
2023,
Wellcome Open Research.
J. Hasenauer,
C. Charpentier,
V. Gaborieau,
2023,
EClinicalMedicine.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Mark S. Anderson,
Chun Jimmie Ye,
P. Gregersen,
2022,
Science Immunology.